Biceltis 440 mg Injection

Get a Price/Quote

Biceltis 440 mg Injection Specification

Salt Composition
Trastuzumab

Origin of Medicine
Biotechnology-derived

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Anticancer Drug

Ingredients
Trastuzumab

Physical Form
Injection

Function
Used to treat HER2-positive breast cancer and stomach cancer

Recommended For
Patients diagnosed with HER2-positive cancer

Dosage
440 mg

Dosage Guidelines
As directed by the healthcare provider; typically administered intravenously in a hospital or clinical setting

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store in a refrigerator (2C to 8C); do not freeze. Keep out of reach of children.

About Biceltis 440 mg Injection

Biceltis 440 mg Injection is an Anticancer Drug containing Trastuzumab in the form of an injectable solution. Specifically designed for patients diagnosed with HER2-positive breast cancer and stomach cancer, each vial contains 440 mg of the drug for intravenous administration in a clinical setting. This biotechnology-derived medication works by targeting HER2 receptors to inhibit cancer cell growth. The product is suitable for adults and should be stored in a refrigerator at 2C to 8C. With one vial per box, Biceltis offers a reliable treatment option for HER2-positive cancer patients.

FAQs of Biceltis 440 mg Injection:

Q: What is the recommended dosage of Biceltis 440 mg Injection?

A: The recommended dosage of Biceltis 440 mg Injection is 440 mg per vial.

Q: How should Biceltis 440 mg Injection be administered?

A: Biceltis 440 mg Injection is typically administered intravenously in a hospital or clinical setting as directed by the healthcare provider.

Q: What is the function of Biceltis 440 mg Injection?

A: Biceltis 440 mg Injection is used to treat HER2-positive breast cancer and stomach cancer by targeting HER2 receptors to inhibit cancer cell growth.